Cardiovascular Health

Surgical procedures and weight-loss drugs combat high hypertension in individuals who are obese or overweight, according to the American Heart Association.

The investigators noted that heart attacks are often caused by the rupturing of vulnerable plaques, defined as plaques with a large lipid core with a thin fibrous cap that serves as a wall or barrier around the plaque to keep it intact.

Pharmacists should stay knowledgeable about recommendations and evidence related to therapies.

Although the cardiovascular condition was thought to be benign, the disease could put pregnant women at greater risk for serious complications during childbirth.

Bleeding in the upper GI tract is among the most common bleeding complications following acute myocardial infarction, causing considerable suffering and increasing the risk of death.

Treatment-emergent serious adverse events were reported more frequently in patients with PVD, which was likely due to their more advanced disease, according to the researchers.

Published results indicate that marriage, urban living put people less at risk for cardiovascular problems.

Because patients may interact with a pharmacist more regularly than other health care providers, it is possible to detect potential signs and symptoms of atrial fibrillation in a patient during their encounters.

The AHA worked with a team of leading health authorities to develop the advisory, which highlights recommendations, algorithms, and guidance for health care professionals and researchers who specialize in heart and brain health.

OSA is associated with cardiovascular disease in adults, but less is known about how the condition affects the immediate and long-term heart health of children and adolescents.

18th century author William Withering popularized the medical use of digitalis, the source for cardiac medication Digoxin.

Additionally, among this population, combining aerobic exercise with a moderate reduction in daily calories resulted in greater improvements in aortic stiffness versus exercise only or exercise plus a more restrictive diet.

How would you answer these patients' questions?

CMS reported that 3.3 million more Medicare Part D beneficiaries with complex health needs than expected between 2013-2018 received a comprehensive medication review as a part of medication therapy management

Ten quiz questions to assess your knowledge on common dyslipidemia treatments.

The goal of treating heart failure is to reduce symptoms, improve heart function, and increase ejection fraction.

ACE inhibitors are currently prescribed more commonly than ARBs as a first-time blood pressure control medicine despite this difference in AEs, the study authors noted.

Reducing blood pressure is the major determinant of reduction in cardiovascular risk in both young and older patients with hypertension.

Selexipag tablets were first approved by the FDA in 2015 to delay disease progression and reduce the risk of hospitalization for PAH.

Lipophilic statins for dyslipidemia penetrate muscle more easily than hydrophilic statins and are associated with a higher incidence of adverse effects.

Women are significantly less likely than men to undergo coronary artery bypass grafting because of gender disparities in the understanding and treatment of coronary artery disease, research shows.

Blood pressure has to be monitored closely in patients diagnosed with stage 1 or 2 hypertension.

Based on their findings, investigators said modifiable risk factors are strongly associated with C-reactive protein levels in patients with coronary artery disease.

Older drugs such as lovastatin (Mevacor, Altoprev), simvastatin (Zocor), and atorvastatin (Lipitor) have the most drug interactions.

According to the investigators, this discrepancy remains even if the individual reported symptoms of heart failure during a routine outpatient health care appointment within the past 6 months.

Heart failure outcomes improve with optimal iron levels.

Ten quiz questions to assess your knowledge on common treatments and counseling points for heart failure.

Men under 55 years of age had a 25% lower risk of heart attack and stroke, whereas men over 60 had a 15% reduced risk with testosterone supplementation.

Ten quiz questions to assess your knowledge on common hypertension treatments.

The new results add to earlier findings from the EMPEROR-Reduced phase 3 trial, which found that empagliflozin reduced the combined relative risk of cardiovascular death or hospitalization for heart failure by 25% compared to placebo.